Tag: Tilray

  • Is Canada’s Medical Cannabis Market Becoming an Oligopoly?

    Is Canada’s Medical Cannabis Market Becoming an Oligopoly?

    March 23rd, 2015 – Growing scientific consensus on cannabis’ medicinal value has sparked the attention of leading players in Canada’s traditional pharmaceutical industry. As Canadians increase their consumption of medicinal cannabis, former pharmaceutical executives are jumping on the bandwagon. As Greg Engel, CEO for Tilray said recently in an online essay for the Huffington Post, “We are…